KEMADRIN Side Effects

6434681-8 | Abdominal Distension, Abdominal Pain, Abdominal Rigidity, Constipation, Faecal Vomiting, Faecaloma, Gastrointestinal Sounds Abnormal, Intestinal Obstruction, Pneumonia Aspiration
on Nov 02, 2009 Male patient from CANADA , 61 years of age, was diagnosed with salivary hypersecretion, schizophrenia, constipation (What is constipation?) and was treated with Kemadrin (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal distension, abdominal pain (What is abdominal pain?), abdominal rigidity, constipation (What is constipation?), faecal vomiting, faecaloma, gastrointestinal sounds abnormal, intestinal obstruction, pneumonia aspiration. Kemadrin dosage: 5 Mg, Bid. During the same period patient was treated with CLOZAPINE (300 Mg, Bid) (View Clozapine Review and Clozapine Label ), OXYBUTYNIN CHLORIDE (5 Mg, Bid) (View Oxybutynin Chloride Review and Oxybutynin Chloride Label ), LAMOTRIGINE (100 Mg, Bid) (View Lamotrigine Review and Lamotrigine Label ), FLURAZEPAM (15 Mg, Qhs) (View Flurazepam Review and Flurazepam Label ), PSYLLIUM (View Psyllium Review and Psyllium Label ), DOCUSATE SODIUM (View Docusate Sodium Review and Docusate Sodium Label ), GLYCERIN (View Glycerin Review and Glycerin Label ). Patient was hospitalized.

5164674-2 | Asthenia, Blood Alcohol Increased, Cardio-respiratory Arrest, Dilatation Ventricular, Pulmonary Infarction, Vomiting
Patient was taking Kemadrin (View Usage). Patient had the following side effects: asthenia, blood alcohol increased, cardio-respiratory arrest, dilatation ventricular, pulmonary infarction, vomiting on Nov 06, 2006 from IRELAND Additional patient health information: Female patient , 36 years of age, was diagnosed with dystonia (What is dystonia?) and. Kemadrin dosage: 20 Mg, (2 Doses, 6 Hours Apart). During the same period patient was treated with FLUPHENAZINE DECANOATE (View Fluphenazine Decanoate Review and Fluphenazine Decanoate Label ), HALOPERIDOL (View Haloperidol Review and Haloperidol Label ).

5150693-9 | Blood Alcohol Increased, Cardio-respiratory Arrest, Dilatation Ventricular
Adverse event was reported on Nov 06, 2006 by a Female patient taking Kemadrin (View Usage) (Dosage: 2 Ml, Bid) was diagnosed with dystonia (What is dystonia?) and. Location: IRELAND , 36 years of age, After Kemadrin was administered, patient had the following side effects: blood alcohol increased, cardio-respiratory arrest, dilatation ventricular. During the same period patient was treated with FLUPHENAZINE DECANOATE (View Fluphenazine Decanoate Review and Fluphenazine Decanoate Label ).

5142311-0 | Unevaluable Event
on Sep 26, 2006 Male patient from UNITED STATES , 70 years of age, was treated with Kemadrin (View Usage). Patient experienced the following unwanted or unexpected effects: unevaluable event. Kemadrin dosage: 25 Mg, Single Dose. During the same period patient was treated with ALBUTEROL SPIROS (View Albuterol Spiros Review and Albuterol Spiros Label ). Patient was hospitalized.


5075092-X | Poor Personal Hygiene, Weight Increased
on Jul 26, 2006 Female patient from UNITED KINGDOM , 45 years of age, was diagnosed with psychotic disorder (What is psychotic disorder?), depression (What is depression?), epilepsy (What is epilepsy?) and was treated with Kemadrin (View Usage). Patient had the following side effects: poor personal hygiene, weight increased. Kemadrin dosage: 10 Mg, Unk. During the same period patient was treated with ABILIFY (30 Mg, Unk) (View Abilify Review and Abilify Label ), FEMODENE (View Femodene Review and Femodene Label ), SOLIAN (View Solian Review and Solian Label ), CITALOPRAM HYDROCHLORIDE (20 Mg, Unk) (View Citalopram Hydrochloride Review and Citalopram Hydrochloride Label ), KEPPRA (2000 Mg, Unk) (View Keppra Review and Keppra Label ), TEGRETOL (600 Mg, Unk) (View Tegretol Review and Tegretol Label ).

5027599-9 | Arrhythmia, Brain Oedema, Cardiotoxicity, Lip Discolouration, Lung Disorder, Neurotoxicity, Oral Discharge, Overdose
Patient was taking Kemadrin (View Usage). After Kemadrin was administered, patient had the following side effects: arrhythmia (What is arrhythmia?), brain oedema, cardiotoxicity, lip discolouration, lung disorder, neurotoxicity, oral discharge, overdose on Jun 06, 2006 from UNITED KINGDOM Additional patient health information: Male patient , 32 years of age, was diagnosed with schizophrenia and. Kemadrin dosage: . During the same period patient was treated with CLOZAPINE (View Clozapine Review and Clozapine Label ), OLANZAPINE (View Olanzapine Review and Olanzapine Label ), DOTHIEPIN HYDROCHLORIDE (View Dothiepin Hydrochloride Review and Dothiepin Hydrochloride Label ), DIAZEPAM (View Diazepam Review and Diazepam Label ).

4896540-1 | Blood Bilirubin Increased, Haemoglobin Decreased, Haemolytic Anaemia, Hyponatraemia
Adverse event was reported on Jan 25, 2006 by a Male patient taking Kemadrin (View Usage) (Dosage: 5 Mg, Qd) was diagnosed with extrapyramidal disorder and. Location: UNITED KINGDOM , 70 years of age, Patient experienced the following unwanted or unexpected effects: blood bilirubin increased, haemoglobin decreased, haemolytic anaemia, hyponatraemia. During the same period patient was treated with BENDROFLUAZIDE (BENDROFLUMETHIAZIDE) (View Bendrofluazide (bendroflumethiazide) Review and Bendrofluazide (bendroflumethiazide) Label ), LEUPROLIDE ACETATE (View Leuprolide Acetate Review and Leuprolide Acetate Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), ESOMEPRAZOLE (View Esomeprazole Review and Esomeprazole Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), ATORVASTATIN CALCIUM (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ), DIHYDROCODEINE (View Dihydrocodeine Review and Dihydrocodeine Label ), ISOSORBIDE MONONITRATE (View Isosorbide Mononitrate Review and Isosorbide Mononitrate Label ).

4875638-8 | Akathisia, Condition Aggravated, Restlessness, Suicidal Ideation
on Jan 03, 2006 Male patient from UNITED KINGDOM , 21 years of age, was diagnosed with akathisia, psychotic disorder (What is psychotic disorder?) and was treated with Kemadrin (View Usage). Patient had the following side effects: akathisia, condition aggravated, restlessness, suicidal ideation. Kemadrin dosage: 5 Mg, Qd. During the same period patient was treated with ARIPIPRAZOLE (15 Mg, Qd) (View Aripiprazole Review and Aripiprazole Label ), CITALOPRAM HYDROBROMIDE (View Citalopram Hydrobromide Review and Citalopram Hydrobromide Label ), CLONAZEPAM (View Clonazepam Review and Clonazepam Label ), RISPERIDONE (View Risperidone Review and Risperidone Label ).

4819148-2 | Akinesia, Bradykinesia, Catatonia, Delusion, Polytraumatism, Psychotic Disorder, Refusal Of Treatment By Patient, Road Traffic Accident
on Oct 24, 2005 Male patient from UNITED KINGDOM , 60 years of age, weighting 176.4 lb, was diagnosed with akinesia, depression (What is depression?) and was treated with Kemadrin (View Usage). After Kemadrin was administered, patient had the following side effects: akinesia, bradykinesia, catatonia, delusion, polytraumatism, psychotic disorder (What is psychotic disorder?), refusal of treatment by patient, road traffic accident. Kemadrin dosage: 5 Mg, Bid. During the same period patient was treated with CITALOPRAM (20 Mg, Qd) (View Citalopram Review and Citalopram Label ), SERTRALINE HCL (View Sertraline Hcl Review and Sertraline Hcl Label ), OXAZEPAM (View Oxazepam Review and Oxazepam Label ), THYROXINE SODIUM (View Thyroxine Sodium Review and Thyroxine Sodium Label ). Patient was hospitalized.

4797248-3 | Akathisia, Balance Disorder, Depressed Level Of Consciousness, Dyskinesia, Musculoskeletal Stiffness, Parkinsonism, Psychomotor Hyperactivity, Restless Legs Syndrome, Tremor
Patient was taking Kemadrin (View Usage). Patient experienced the following unwanted or unexpected effects: akathisia, balance disorder, depressed level of consciousness, dyskinesia, musculoskeletal stiffness, parkinsonism, psychomotor hyperactivity, restless legs syndrome, tremor on Aug 31, 2005 from UNITED KINGDOM Additional patient health information: Male patient , 58 years of age, weighting 103.6 lb, was diagnosed with extrapyramidal disorder and. Kemadrin dosage: 5 Mg, Unk. During the same period patient was treated with CHLORPROMAZINE HCL (View Chlorpromazine Hcl Review and Chlorpromazine Hcl Label ), DONEPEZIL HYDROCHLORIDE (View Donepezil Hydrochloride Review and Donepezil Hydrochloride Label ), SERTRALINE HCL (View Sertraline Hcl Review and Sertraline Hcl Label ).

4782778-0 | Dyskinesia, Psoriasis, Skin Disorder
Adverse event was reported on Sep 20, 2005 by a Male patient taking Kemadrin (View Usage) (Dosage: 10 Mg, Unk) . Location: UNITED KINGDOM , 27 years of age, Patient had the following side effects: dyskinesia, psoriasis, skin disorder. During the same period patient was treated with FLUPENTIXOL (View Flupentixol Review and Flupentixol Label ), LARGACTIL (View Largactil Review and Largactil Label ), PIPOTHIAZINE (View Pipothiazine Review and Pipothiazine Label ), BUPRENORPHINE HCL (View Buprenorphine Hcl Review and Buprenorphine Hcl Label ), DIAMORPHINE HYDROCHLORIDE (View Diamorphine Hydrochloride Review and Diamorphine Hydrochloride Label ), COCAINE (Unk, Unk) (View Cocaine Review and Cocaine Label ).

4779410-9 | Balance Disorder, Depressed Level Of Consciousness, Dyskinesia, Musculoskeletal Stiffness, Parkinsonism, Psychomotor Hyperactivity, Tremor
on Aug 31, 2005 Male patient from UNITED KINGDOM , 58 years of age, weighting 103.6 lb, was diagnosed with extrapyramidal disorder and was treated with Kemadrin (View Usage). After Kemadrin was administered, patient had the following side effects: balance disorder, depressed level of consciousness, dyskinesia, musculoskeletal stiffness, parkinsonism, psychomotor hyperactivity, tremor. Kemadrin dosage: 5 Mg, Unk. During the same period patient was treated with CHLORPROMAZINE HCL (View Chlorpromazine Hcl Review and Chlorpromazine Hcl Label ), DONEPEZIL HYDROCHLORIDE (View Donepezil Hydrochloride Review and Donepezil Hydrochloride Label ), SERTRALINE HCL (View Sertraline Hcl Review and Sertraline Hcl Label ).